Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: Implications for a proper understanding of type-specific persistent infections

Journal of Infectious Diseases

Volumn 202, Issue 11, 2010, Pages 1667-1670

  Xi, Long Fu ^a,b   Koutsky, Laura A ^b   Castle, Philip E ^c   Edelstein, Zoe R ^b   Hulbert, Ayaka ^a   Schiffman, Mark ^c   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DNA SEQUENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 78649533141     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657083     Document Type: Article

References (15)

1. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996; 88:261-268.
2. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27.
3. Franco EL, Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 1994; 86:1558-1559.
4. Bernard HU, Chan SY, Delius H. Evolution of papillomaviruses. Curr Top Microbiol Immunol 1994; 186:33-54.
5. Schiffman M, Adrianza ME; ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000; 44:726-742.
6. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
7. Xi LF, Kiviat NB, Hildesheim A, et al. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 2006; 98:1045-1052. (Pubitemid 44288152)
8. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997; 71:2463-2472.
9. Jiang M, Xi LF, Edelstein ZR, et al. Identification of recombinant human papillomavirus type 16 variants. Virology 2009; 394:8-11.
10. Lydersen S, Fagerland MW, Laake P. Recommended tests for association in 2 x 2 tables. Stat Med 2009; 28:1159-1175.
11. Xi LF, Demers GW, Koutsky LA, et al. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 1995; 172:747-755.
12. van Belkum A, Juffermans L, Schrauwen L, van Doornum G, Burger M, Quint W. Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J Clin Microbiol 1995; 33:2957-2962.
13. Mayrand MH, Coutlee F, Hankins C, et al. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 2000; 38:3388-3393.
14. Steinau M, Swan DC, Onyekwuluje JM, et al. Differences and changes in human papillomavirus 16 variant status in human immunodeficiency virus-positive adults are not uncommon. J Gen Virol 2010; 91:2068-2072.
15. Khouadri S, Villa LL, Gagnon S, et al. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis 2006; 194:886-894.